Clinical Trial

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.
Protocol Amendment History 3 changes
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-05-29
notable Primary completion pushed: 2026-07-15 -> 2026-10-07 2026-05-29
minor Completion pushed: 2026-07-22 -> 2026-10-14 2026-05-29
Trial Details
NCT Number NCT07300280
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 60 participants
Start Date 2025-12-29
Primary Completion 2026-10-14 (estimated)
Study Completion 2026-10-21 (estimated)
Updated on ClinicalTrials.gov 2026-06-09